Corvus registers Phase 1b trial of soquelitinib in hidradenitis suppurativaSep 18Trial updateCorvus Pharmaceuticals, Inc.soquelitinib
Corvus reports Q2 2026 results, updates soquelitinib pipeline progressAug 6Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib
Corvus Pharmaceuticals board member Ian T. Clark to resign, effective July 22, 2026Jul 22PeopleCorvus Pharmaceuticals, Inc.
Sign in